Efficacy of sarilumab and dexamethasone co-administration for lowering multiple blood biomarkers in the treatment of cytokine release syndrome in hospitalized covid-19 patients

The current study was planned to explore the potential synergistic role of the co-administration of sarilumab and dexamethasone in reducing blood biomarkers associated with cytokine release syndrome in hospitalised patients of coronavirus disease-2019. The sample comprised 22 patients hospitalised...

Full description

Saved in:
Bibliographic Details
Main Authors: Ishtiaq Ahmad, Hamidullah
Format: Article
Language:English
Published: Pakistan Medical Association 2024-06-01
Series:Journal of the Pakistan Medical Association
Subjects:
Online Access:https://jpma.org.pk/index.php/public_html/article/view/10480
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items